WCG Executive and Leadership Team

Sam Srivastava, the Chief Executive Officer at WCG, directs the overarching corporate strategy and operational execution. Srivastava guides the company's mission to measurably improve the quality and efficiency of clinical trials, directly impacting the development of new treatments and therapies for patients. This leadership role involves aligning all departments toward achieving WCG's core objectives in the biopharmaceutical and institutional sectors. Srivastava ensures the company's strategic direction supports innovation and accelerates the delivery of life-changing medical advancements. The Chief Executive Officer's focus remains on driving sustainable growth and enhancing WCG's market position as a leader in clinical trial facilitation. Sam Srivastava's vision propels the organization forward, emphasizing collaboration and excellence across all facets of the business.

Anthony Doyle, the Chief Financial Officer at WCG, manages the company's financial operations and strategic fiscal planning. Doyle oversees all aspects of financial reporting, budgeting, forecasting, and capital allocation to support WCG's growth objectives. This leadership position involves ensuring financial stability and optimizing resource deployment to enhance the efficiency of clinical trials and the development of new therapies. The Chief Financial Officer's role is critical in maintaining investor confidence and driving profitability while adhering to stringent industry regulations. Anthony Doyle's expertise guides financial strategies that enable WCG to measurably improve trial quality and accelerate the delivery of innovative treatments to patients. His stewardship ensures robust financial health, supporting WCG's mission to advance medical science.

Todd Joron, the Co-Founder & Wcg Imaging President & Chief Operating Officer at WCG, drives operational excellence and strategic growth across WCG Imaging and the broader organization. Joron oversees the day-to-day operations, ensuring the efficient delivery of services that measurably improve clinical trial quality and accelerate the development of new therapies. This leadership position involves optimizing processes, managing resources, and fostering innovation within WCG Imaging and other operational units. The Co-Founder & Wcg Imaging President & Chief Operating Officer's focus is on enhancing operational capabilities to support WCG's mission of bringing life-changing treatments to patients faster. Todd Joron's deep understanding of the company's founding principles guides operational strategies, ensuring alignment with WCG's commitment to quality and efficiency in clinical research.

Andrew Saenz, the President, Intellectual Property Services at WCG, leads the strategic management and protection of the company's intellectual assets. Saenz oversees the development and implementation of policies and procedures that safeguard WCG's innovations and proprietary technologies, crucial for maintaining its competitive edge in improving clinical trial quality. This role involves ensuring that WCG's intellectual property portfolio effectively supports the company's mission to facilitate the development of new treatments and therapies. The President, Intellectual Property Services' responsibilities include navigating complex legal landscapes and maximizing the value derived from WCG's intellectual capital. Andrew Saenz's expertise ensures that WCG's innovations are protected, enabling continued advancement in the biopharmaceutical research sector and supporting the delivery of novel medical solutions to patients.

Cynthia Carter, the President, MI & I at WCG, spearheads initiatives within Medical Information and Innovation. Carter directs the strategic development and implementation of programs aimed at enhancing WCG's capabilities in clinical trial quality and efficiency. This leadership position focuses on leveraging medical insights and innovative approaches to accelerate the development of new treatments and therapies for patients. The President, MI & I's responsibilities include fostering advancements in medical information systems and driving innovative solutions that benefit biopharmaceutical companies and research institutions. Cynthia Carter ensures that WCG remains at the forefront of medical innovation, contributing significantly to the advancement of healthcare solutions. Her leadership drives progress in critical areas of medical research and development.

Paul Mancinelli, the Chief Technology Officer at WCG, architects the company's technological infrastructure and digital transformation initiatives. Mancinelli oversees the development and implementation of innovative solutions that enhance the quality and efficiency of clinical trials. This involves leveraging cutting-edge technology to streamline data management, improve patient recruitment, and ensure regulatory compliance across global research projects. The Chief Technology Officer's responsibilities extend to safeguarding WCG's digital assets and driving technological advancements that support the rapid development of new treatments. Paul Mancinelli ensures that WCG's technological capabilities remain at the forefront of the industry, enabling faster and more effective therapeutic breakthroughs. His leadership drives the integration of advanced systems to optimize trial processes and deliver superior outcomes for biopharmaceutical companies and institutions.

Michael Passanante, the Chief Marketing Officer at WCG, directs the company's global marketing strategies and brand development initiatives. Passanante oversees the creation and execution of campaigns designed to enhance WCG's market presence and communicate the value of its services in improving clinical trial quality and efficiency. This role involves understanding market dynamics to effectively position WCG's solutions for biopharmaceutical companies, CROs, and institutions. The Chief Marketing Officer's focus is on driving demand, fostering client engagement, and highlighting WCG's contribution to the development of new treatments. Michael Passanante ensures that WCG's brand narrative accurately reflects its commitment to accelerating therapeutic innovation and reaching patients in need. His leadership amplifies WCG's impact by connecting its expertise with the broader healthcare ecosystem.

Antonio Castillo, the Director, Chief Revenue Officer Partnerships at WCG, cultivates and manages strategic alliances to drive revenue growth and expand market reach. Castillo oversees the development of key partnerships that enhance WCG's ability to improve clinical trial quality and efficiency. This involves identifying and engaging with collaborators who can amplify WCG's impact on the development of new treatments and therapies. The Director, Chief Revenue Officer Partnerships' responsibilities include fostering strong relationships with industry stakeholders to create mutually beneficial opportunities. Antonio Castillo ensures that partnership strategies align with WCG's overall mission to accelerate medical innovation and deliver value to clients. His efforts are instrumental in broadening WCG's network and enhancing its capacity to serve the biopharmaceutical sector effectively.

Elisa Calicchio, the Chief Human Resources Officer at WCG, leads the company's human capital strategy and talent management initiatives. Calicchio oversees the development and implementation of programs that attract, retain, and develop a high-performing workforce dedicated to improving clinical trial quality and efficiency. This role is crucial in fostering a culture of innovation and collaboration that supports the rapid development of new treatments and therapies. The Chief Human Resources Officer's responsibilities include ensuring WCG has the skilled personnel necessary to meet the evolving demands of the biopharmaceutical industry. Elisa Calicchio champions employee engagement and professional growth, aligning HR functions with WCG's strategic objectives. Her leadership ensures WCG remains an employer of choice, driving success through its people.

Jared Zane, the Chief Legal Officer & Corporate Secretary at WCG, provides comprehensive legal counsel and oversees corporate governance. Zane directs all legal affairs, ensuring WCG operates in compliance with relevant regulations and industry standards, which is vital for maintaining the integrity of clinical trials. This leadership role involves managing legal risks, advising on corporate strategy, and supporting the company's mission to measurably improve the quality and efficiency of developing new treatments. The Chief Legal Officer & Corporate Secretary's responsibilities include safeguarding WCG's interests and facilitating smooth corporate operations. Jared Zane's guidance ensures that WCG's legal framework robustly supports its commitment to advancing medical science and bringing therapies to patients safely and effectively.